Welcome to LookChem.com Sign In|Join Free

CAS

  • or

151917-39-4

Post Buying Request

151917-39-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

151917-39-4 Usage

General Description

6-Iodopyridine-3-carboxylic acid ethyl ester is a chemical compound with the molecular formula C8H8INO2. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 6-Iodopyridine-3-carboxylic acid ethyl ester is a derivative of pyridine and contains both iodine and ethyl ester functional groups. It can be used in the production of various drugs and medical compounds due to its high reactivity and ability to undergo a variety of chemical reactions. Additionally, it is also used as a building block in organic synthesis and can be employed in the development of new molecules for medicinal and industrial purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 151917-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,9,1 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 151917-39:
(8*1)+(7*5)+(6*1)+(5*9)+(4*1)+(3*7)+(2*3)+(1*9)=134
134 % 10 = 4
So 151917-39-4 is a valid CAS Registry Number.

151917-39-4Relevant articles and documents

Discovery of a potent and brain penetrant mGluR5 positive allosteric modulator

Ritzen, Andreas,Sindet, Rikke,Hentzer, Morten,Svendsen, Nannette,Brodbeck, Robbin M.,Bundgaard, Christoffer

supporting information; experimental part, p. 3275 - 3278 (2010/03/24)

This Letter describes the discovery of a novel series of mGluR5 positive allosteric modulators (PAMs). The lead compound, 11c, exhibits excellent potency (EC50 = 30 nM) in vitro, and reaches high brain levels in both rats and mice after oral ad

Evaluation of radiolabeled (Hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma

Chezal, Jean-Michel,Papon, Janine,Labarre, Pierre,Lartigue, Claire,Galmier, Marie-Josephe,Decombat, Caroline,Chavignon, Olivier,Maublant, Jean,Teulade, Jean-Claude,Madelmont, Jean-Claude,Moins, Nicole

experimental part, p. 3133 - 3144 (2009/04/07)

Targeted radionuclide therapy using radioiodinated compounds with a specific affinity for melanoma tissue is a promising treatment for disseminated melanoma, but the candidate with the ideal kinetic profile remains to be discovered. Targeted radionuclide therapy concentrates the effects on tumor cells, thereby increasing the efficacy and decreasing the morbidity of radiotherapy. In this context, analogues of N-(2-diethylaminoethyl)-4- iodobenzamide (BZA) are of interest. Various (hetero)aromatic analogues 5 of BZA were synthesized and radioiodinated with 125I, and their biodistribution in melanoma-bearing mice was studied after i.v. administration. Most [125I]5-labeled compounds appeared to bind specifically and with moderate-to-high affinity to melanoma tumor. Two compounds, 5h and 5k, stood out with high specific and long-lasting uptake in the tumor, with a 7- and 16-fold higher value than BZA at 72 h, respectively, and kinetic profiles that makes them promising agents for internal targeted radionuclide therapy of melanoma.

Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity

-

Page column 18, (2010/01/30)

Compounds of the formula where R1and R2, independently are alkyl groups having 2 to 8 carbons; R3is hydrogen or lower alkyl; X is S, O or N—R4where R4is hydrogen or lower alkyl; Y is phenyl or pyridyl

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 151917-39-4